Procter & Gamble Health Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Standalone Quarterly Results

Jun'26

Mar'26

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Quarterly Analysis Highlights - YoY

Net Sales

YoY Growth in quarter ended Jun 2026 is 7.37% vs 19.33% in Jun 2025

Standalone Net Profit

YoY Growth in quarter ended Jun 2026 is 45.29% vs 294.40% in Jun 2025

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2026 is 10.25% vs 87.23% in Jun 2025

Interest

YoY Growth in quarter ended Jun 2026 is 16.67% vs -40.00% in Jun 2025

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025

Compare Quarterly Results Of P & G Health Ltd With

Select Peers

Figures in Cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

363.71

293.11

70.60

24.09%

Other Operating Income

0.00

Total Operating income

363.71

293.11

70.60

24.09%

Raw Material Cost

80.31

178.88

-98.57

-55.10%

Purchase of Finished goods

24.56

0.00

24.56

(Increase) / Decrease In Stocks

-8.65

-41.77

33.12

79.29%

Employee Cost

60.39

20.12

40.27

200.15%

Power Cost

0.00

Manufacturing Expenses

0.00

Selling and Distribution Expenses

0.00

Other Expenses

107.50

37.80

69.70

184.39%

Total Expenditure (Excl Depreciation)

264.11

195.03

69.08

35.42%

Operating Profit (PBDIT) excl Other Income

99.60

98.08

1.52

1.55%

Other Income

3.88

15.24

-11.36

-74.54%

Operating Profit (PBDIT)

103.48

113.32

-9.84

-8.68%

Interest

0.14

0.66

-0.52

-78.79%

Exceptional Items

31.80

0.00

31.80

Gross Profit (PBDT)

135.14

112.66

22.48

19.95%

Depreciation

6.02

6.71

-0.69

-10.28%

Profit Before Tax

129.12

105.95

23.17

21.87%

Tax

32.97

27.68

5.29

19.11%

Provisions and contingencies

0.00

Profit After Tax

96.15

78.26

17.89

22.86%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

96.15

78.26

17.89

22.86%

Equity Capital

16.60

34.69

-18.09

-52.15%

Face Value

10.00

2.00

0.00

Reserves

0.00

Earnings per share (EPS)

57.92

4.51

53.41

1,184.26%

Diluted Earnings per share

57.92

4.51

53.41

1,184.26%

Operating Profit Margin (Excl OI)

27.38%

33.46%

0.00

-6.08%

Gross Profit Margin

37.16%

38.44%

0.00

-1.28%

PAT Margin

26.44%

26.70%

0.00

-0.26%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 363.71 Cr

in Jun 2026

Figures in Cr

QoQ Growth in quarter ended Jun 2026 is -1.82% vs -0.91% in Mar 2026

YoY Growth in quarter ended Jun 2026 is 7.37% vs 19.33% in Jun 2025

Quarterly - Standalone Net Profit

Standalone Net Profit 96.15 Cr

in Jun 2026

Figures in Cr

QoQ Growth in quarter ended Jun 2026 is 1.64% vs 21.92% in Mar 2026

YoY Growth in quarter ended Jun 2026 is 45.29% vs 294.40% in Jun 2025

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 99.60 Cr

in Jun 2026

Figures in Cr

QoQ Growth in quarter ended Jun 2026 is -26.54% vs 22.75% in Mar 2026

YoY Growth in quarter ended Jun 2026 is 10.25% vs 87.23% in Jun 2025

Quarterly - Interest

Interest 0.14 Cr

in Jun 2026

Figures in Cr

QoQ Growth in quarter ended Jun 2026 is -33.33% vs 110.00% in Mar 2026

YoY Growth in quarter ended Jun 2026 is 16.67% vs -40.00% in Jun 2025

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 27.38%

in Jun 2026

Figures in %

QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025